We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No Kodak moment

6 Jul 2017 By Robert Cyran

The Japanese company that abandoned cameras for copiers a decade ago is now putting its focus squarely on medical diagnostics. An up-to-$1 bln acquisition of Ambry Genetics alone won’t assure Konica Minolta’s future. It is, however, an affordable way to start changing its DNA.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)